Thank you, Mr. Chair.
Thank you for being here.
We return from whence we began. Dr. Gagnon, Professor Morgan, we called you back to bookend this because you testified at the beginning of this study some 18 months ago. I'm going to be addressing my questions to you, if I can, as two of the world's pre-eminent researchers on pharmaceutical policy.
It seems to me now that every serious, non-biased, peer-reviewed study of universal pharmacare in Canada concludes as follows: one, that millions of Canadians can't afford the medicine prescribed by their doctors; two, that Canadians pay among the highest prices for pharmaceuticals in the world; three, that we can ensure that universal coverage could be brought to all Canadians through a public system; and four, that we will save billions of dollars collectively in doing so.
My first question is, Dr. Gagnon, Professor Morgan, do I have those points correct?